Literature DB >> 74646

Incidence of retrolental fibroplasia.

T R Gunn, J V Aranda, J Little.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 74646     DOI: 10.1016/s0140-6736(78)90660-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Eleven years' experience with retinopathy of prematurity: visual results and contribution of cryoablation.

Authors:  I Nissenkorn; I Ben Sira; I Kremer; D D Gaton; R Krikler; E Wielunsky; P Merlob
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

2.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Retinopathy of prematurity: oxygen dogma challenged.

Authors:  W A Silverman
Journal:  Arch Dis Child       Date:  1982-10       Impact factor: 3.791

4.  Retrolental fibroplasia may not be preventable.

Authors:  J F Lucey
Journal:  J R Soc Med       Date:  1982-07       Impact factor: 5.344

5.  Retinopathy of prematurity: review of a four-year period.

Authors:  B P Cats; K E Tan
Journal:  Br J Ophthalmol       Date:  1985-07       Impact factor: 4.638

6.  Ocular sequelae of preterm birth and their relation to ultrasound evidence of cerebral damage.

Authors:  J Hungerford; A Stewart; P Hope
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

7.  Are severe acute retinopathy of prematurity and severe periventricular leucomalacia both ischaemic insults?

Authors:  Y K Ng; A R Fielder; M I Levene; J Q Trounce; N McLellan
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

8.  Intravenous indomethacin for patent ductus arteriosus.

Authors:  I J Smith; I Goss; P J Congdon
Journal:  Arch Dis Child       Date:  1984-06       Impact factor: 3.791

9.  Treatment of acute retrolental fibroplasia by cryopexy.

Authors:  I Ben-Sira; I Nissenkorn; E Grunwald; Y Yassur
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.